Closed End Fund Advisors Inc. acquired a new position in BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 36,623 shares of the company’s stock, valued at approximately $519,000.
Several other institutional investors also recently modified their holdings of the stock. Lido Advisors LLC increased its position in shares of BlackRock Capital Allocation Term Trust by 1,243.1% in the fourth quarter. Lido Advisors LLC now owns 180,590 shares of the company’s stock worth $2,566,000 after purchasing an additional 167,144 shares during the last quarter. Global Retirement Partners LLC increased its position in shares of BlackRock Capital Allocation Term Trust by 1,856.5% in the fourth quarter. Global Retirement Partners LLC now owns 8,687 shares of the company’s stock worth $123,000 after purchasing an additional 8,243 shares during the last quarter. Wolverine Asset Management LLC bought a new position in shares of BlackRock Capital Allocation Term Trust in the fourth quarter worth approximately $2,565,000. Oppenheimer & Co. Inc. increased its position in shares of BlackRock Capital Allocation Term Trust by 8.2% in the fourth quarter. Oppenheimer & Co. Inc. now owns 50,916 shares of the company’s stock worth $721,000 after purchasing an additional 3,873 shares during the last quarter. Finally, N.E.W. Advisory Services LLC increased its position in shares of BlackRock Capital Allocation Term Trust by 100.0% in the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock worth $34,000 after purchasing an additional 1,200 shares during the last quarter. 36.12% of the stock is currently owned by institutional investors.
BlackRock Capital Allocation Term Trust Stock Performance
BCAT stock opened at $15.49 on Friday. The company’s 50 day moving average is $15.10 and its 200 day moving average is $14.77. BlackRock Capital Allocation Term Trust has a 1-year low of $13.73 and a 1-year high of $15.98.
About BlackRock Capital Allocation Term Trust
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
Recommended Stories
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
